Elimination of NF-κB signaling in Vimentin plus stromal cells attenuates tumorigenesis in a mouse model of Barrett's Esophagus

Chronic inflammation induces Barrett's Esophagus (BE) which can advance to esophageal adenocarcinoma. Elevated levels of interleukin (IL)-1b, IL-6 and IL-8 together with activated nuclear factor-kappaB (NF-kappa B), have been identified as important mediators of tumorigenesis. The inflammatory milieu apart from cancer cells and infiltrating immune cells contains myofibroblasts (MFs) that express aSMA and Vimentin. As we observed that increased NF-kappa B activation and inflammation correlates with increased MF recruitment and an accelerated phenotype we here analyze the role of NF-kappa B in MF during esophageal carcinogenesis in our L2-IL-1B mouse model. To analyze the effect of NF-kappa B signaling in MFs, we crossed L2-IL-1B mice to tamoxifen inducible Vim-Cre (Vim-CreTm) mice and floxed ReIA (p65(fl/fl)) mice to specifically eliminate NF-kappa B signaling in MF (IL-1b.Vim-CreTm.p65(fl/fl)). The interaction of epithelial cells and stromal cells was further analyzed in mouse BE organoids and patient-derived human organoids. Histological scoring of IL-1b.Vim-CreTm.p65(fl/fl) mice showed a significantly attenuated phenotype compared with L2-IL-1B mice, with mild inflammation, decreased metaplasia and no dysplasia. This correlated with decreased proliferation and increased differentiation in cardia tissue of IL-1b.Vim-CreTm.p65(fl/fl) compared with L2-IL-1B mice. Distinct changes of cytokines and chemokines within the local microenvironment in IL-1b.Vim-CreTm.p65(fl/fl) mice reflected the histopathological abrogated phenotype. Co-cultured NF-kappa B inhibitor treated MF with mouse BE organoids demonstrated NF-kappa B-dependent growth and migration. MFs are essential to form an inflammatory and procarcinogenic microenvironment and NF-kappa B signaling in stromal cells emerges as an important driver of esophageal carcinogenesis. Our data suggest anti-inflammatory approaches as preventive strategies during surveillance of BE patients.

Automated summary

Chronic inflammation leads to Barrett's Esophagus (BE) and can progress to esophageal adenocarcinoma. Elevated levels of interleukins and NF-kappaB activation play a crucial role in tumorigenesis. Inhibiting NF-kappaB signaling in myofibroblasts (MFs) can reduce inflammation, increase differentiation, and decrease the risk of esophageal adenocarcinoma development.